Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
The treatment of schistosomiasis, a disease caused by blood flukes parasites of the Schistosoma genus, depends on the intensive use of a single drug, praziquantel, which increases the likelihood of the development of drug-resistant parasite strains and renders the search for new drugs a strategic priority. Currently, inhibitors of human epigenetic enzymes are actively investigated as novel anti-cancer drugs and have the potential to be used as new anti-parasitic agents. Here, we report that Schistosoma mansoni histone deacetylase 8 (smHDAC8), the most expressed class I HDAC isotype in this organism, is a functional acetyl-L-lysine deacetylase that plays an important role in parasite infectivity. The crystal structure of smHDAC8 shows that this enzyme adopts a canonical α/β HDAC fold, with specific solvent exposed loops corresponding to insertions in the schistosome HDAC8 sequence. Importantly, structures of smHDAC8 in complex with generic HDAC inhibitors revealed specific structural changes in the smHDAC8 active site that cannot be accommodated by human HDACs. Using a structure-based approach, we identified several small-molecule inhibitors that build on these specificities. These molecules exhibit an inhibitory effect on smHDAC8 but show reduced affinity for human HDACs. Crucially, we show that a newly identified smHDAC8 inhibitor has the capacity to induce apoptosis and mortality in schistosomes. Taken together, our biological and structural findings define the framework for the rational design of small-molecule inhibitors specifically interfering with schistosome epigenetic mechanisms, and further support an anti-parasitic epigenome targeting strategy to treat neglected diseases caused by eukaryotic pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have previously shown that our smHDAC8 crystals can be used to look at inhibitor binding in a crystal latticeunbiased manner 29, 30, 55-58 .”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we previously observed a very similar binding mode to smHDAC8 for another pan-HDAC inhibitor, M344, including an interaction between D100 and the M344 internal amide group 30”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Each experiment was repeated 3–5 times and analyzed using the DDCt method [53].”
Method[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · cited 3×
“8 Å resolution was solved by molecular replacement with Phenix [57] using the hHDAC8 structure (PDB 1T69) as a search model.”
MethodInfluentialJalview Version 2—a multiple sequence alignment editor and analysis workbench
Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,235
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690 · cited 1×
“Alignments were generated with JalView [61], structural panels in figures were generated with PyMOL (DeLano Scientific), and schematic interactions of the inhibitors with smHDAC8 were generated with LigPlot [62]).”
MethodJones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Research works printed but not linked: 1
- KJ Prasad, 2010, Emerging and re-emerging parasitic diseases, J Int Med Sci Acad, 23, 45
Cited by
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Mottamal, M., Zheng, S., Huang, T., & Wang, G. (2015) · Molecules · doi:10.3390/molecules20033898 · Cited by 680
“For example, a potential inhibitor of Schistosoma mansoni HDAC8 (smHDAC8) for the treatment of schistosomiasis, a parasitic disease caused by blood flukes of the genus Schistosoma, was identified by screening the Enamine purchasable compound library [193].”
BackgroundInside HDACs with more selective HDAC inhibitors
Roche, J., & Bertrand, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.047 · Cited by 312
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Self-citationTargeting Class I Histone Deacetylases in a “Complex” Environment
Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180
“Interestingly, structural differences between HDAC8 in humans and the blood fluke Schistosoma mansoni suggest that it may be possible to use HDAC inhibitors as antiparasitic agents [89].”
BackgroundInnovation in neglected tropical disease drug discovery and development
Weng, H.-B., Chen, H.-X., & Wang, M.-W. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0444-1 · Cited by 161
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Zagni, C., Floresta, G., Monciino, G., & Rescifina, A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21437 · Cited by 132
Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Cappellacci, L., Perinelli, D. R., Maggi, F., Grifantini, M., & Petrelli, R. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867325666181016163110 · Cited by 130
Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
Banik, D., Moufarrij, S., & Villagra, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092241 · Cited by 133
Heimburg, T., Chakrabarti, A., Lancelot, J., Marek, M., Melesina, J., Hauser, A.-T., Shaik, T. B., Duclaud, S., Robaa, D., Erdmann, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01478 · Cited by 124
Self-citationMarek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 122
Self-citationStrategies To Design Selective Histone Deacetylase Inhibitors
Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118
Self-citationSenger, J., Melesina, J., Marek, M., Romier, C., Oehme, I., Witt, O., Sippl, W., & Jung, M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01493 · Cited by 112
“HDAC8 enzyme was obtained as described before.(37)”
Self-citationHistone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 108
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., Wang, D., Hayatshahi, H. S., Shen, Y., Liu, J., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908713 · Cited by 116
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0117 · Cited by 111
Self-citationLysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives
Hailu, G. S., Robaa, D., Forgione, M., Sippl, W., Rotili, D., & Mai, A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01595 · Cited by 103
Self-citationChua, M. J., Arnold, M. S. J., Xu, W., Lancelot, J., Lamotte, S., Späth, G. F., Prina, E., Pierce, R. J., Fairlie, D. P., Skinner‐Adams, T. S., et al. (2016) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2016.12.005 · Cited by 108
“, 2012b, 2012c) or significant differences in important catalytic domains (Marek et al., 2013; Melesina et al., 2015) that make them attractive anti-parasitic drug targets.”
BackgroundSelf-citationVögerl, K., Ong, N., Senger, J., Herp, D., Schmidtkunz, K., Marek, M., Müller, M., Bartel, K., Shaik, T. B., Porter, N. J., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01090 · Cited by 104
Self-citationEnzyme Tunnels and Gates As Relevant Targets in Drug Design
Marques, S. M., Daniel, L., Buryska, T., Prokop, Z., Brezovsky, J., & Damborsky, J. (2017) · Medicinal Research Reviews · doi:10.1002/med.21430 · Cited by 98
Heimburg, T., Kolbinger, F. R., Zeyen, P., Ghazy, E., Herp, D., Schmidtkunz, K., Melesina, J., Shaik, T. B., Erdmann, F., Schmidt, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01447 · Cited by 92
Self-citationHDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Kang, Y., Nian, H., Rajendran, P., Kim, E., Dashwood, W. M., Pinto, J. T., Boardman, L. A., Thibodeau, S. N., Limburg, P. J., Löhr, C. V., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.422 · Cited by 82
Pathological Role of HDAC8: Cancer and Beyond
Kim, J. Y., Cho, H., Yoo, J. H., Kim, G. W., Jeon, Y. H., Lee, S. W., & Kwon, S. H. (2022) · Cells · doi:10.3390/cells11193161 · Cited by 89
Stolfa, D. A., Marek, M., Lancelot, J., Hauser, A.-T., Walter, A., Leproult, E., Melesina, J., Rumpf, T., Wurtz, J.-M., Cavarelli, J., et al. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.03.007 · Cited by 75
“Interestingly, just by exchange of the zinc-coordinating warhead, a completely different bindingmode of 1a as compared toSAHA is observed [17], although spacer and capping group are the same.”
BackgroundMethodInfluentialSelf-citationAndrade, L. F., Mourão, M. D. M., Geraldo, J. A., Coelho, F. S., Silva, L. L., Neves, R. H., Volpini, Â. C., Machado-Silva, J. R., Araújo, N., Nacif-Pimenta, R., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002949 · Cited by 82
“mansoni genes were generated from PCR products of approximately 500 bp that had been amplified from schistosomula cDNA using the T7 RiboMAX Express RNAi Kit (Promega) as described elsewhere [23,27].”
MethodSelf-citationCarneiro, V. C., da Silva, I. C. D. A., Torres, E. J. L., Caby, S., Lancelot, J., Vanderstraete, M., Furdas, S. D., Jung, M., Pierce, R. J., & Fantappíé, M. R. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004116 · Cited by 70
Self-citationRoquis, D., Lepesant, J. M. J., Picard, M., Freitag, M., Parrinello, H., Groth, M., Emans, R., Cosseau, C., & Grunau, C. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003853 · Cited by 70
Tabackman, A. A., Frankson, R., Marsan, E. S., Perry, K., & Cole, K. E. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.06.023 · Cited by 60
Kannan, S., Melesina, J., Hauser, A.-T., Chakrabarti, A., Heimburg, T., Schmidtkunz, K., Walter, A., Marek, M., Pierce, R. J., Romier, C., et al. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5004653 · Cited by 60
Self-citationTargeting histone acetylation/deacetylation in parasites: an update (2017–2020)
Fioravanti, R., Mautone, N., Rovere, A., Rotili, D., & Mai, A. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.05.008 · Cited by 61
The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs
Geurs, S., Clarisse, D., De Bosscher, K., & D’hooghe, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00226 · Cited by 58
Targeting Lysine Deacetylases (KDACs) in Parasites
Wang, Q., Rosa, B. A., Nare, B., Powell, K., Valente, S., Rotili, D., Mai, A., Marshall, G. R., & Mitreva, M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004026 · Cited by 60
Epigenetic control of gene function in schistosomes: a source of therapeutic targets?
Cabezas‐Cruz, A., Lancelot, J., Caby, S., Oliveira, G., & Pierce, R. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00317 · Cited by 56
Self-citationNovel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
Brindisi, M., Senger, J., Cavella, C., Grillo, A., Chemi, G., Gemma, S., Cucinella, D. M., Lamponi, S., Sarno, F., Iside, C., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.069 · Cited by 57
Self-citationStenzel, K., Hamacher, A., Hansen, F. K., Gertzen, C. G. W., Senger, J., Marquardt, V., Marek, L., Marek, M., Romier, C., Remke, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01538 · Cited by 51
Self-citationDiscovery of Novel Antischistosomal Agents by Molecular Modeling Approaches
Mafud, A. C., Ferreira, L. L. G., Mascarenhas, Y. P., Andricopulo, A. D., & de Moraes, J. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.08.002 · Cited by 49
“32 mM), which displayed moderate selectivity for the parasite enzyme (Figure 4A) [15].”
BackgroundSinatra, L., Vogelmann, A., Friedrich, F., Tararina, M. A., Neuwirt, E., Colcerasa, A., König, P., Toy, L., Yesiloglu, T. Z., Hilscher, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01385 · Cited by 47
Self-citationChemotherapy for Fighting Schistosomiasis: Past, Present and Future
Mäder, P., Rennar, G. A., Ventura, A. M. P., Grevelding, C. G., & Schlitzer, M. (2018) · ChemMedChem · doi:10.1002/cmdc.201800572 · Cited by 48
Melesina, J., Robaa, D., Pierce, R. J., Romier, C., & Sippl, W. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.10.006 · Cited by 51
Self-citationWhatley, K. C. L., Padalino, G., Whiteland, H., Geyer, K. K., Hulme, B. J., Chalmers, I. W., Forde-Thomas, J., Ferla, S., Brancale, A., & Hoffmann, K. F. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007693 · Cited by 45
Darwish, S., Ghazy, E., Heimburg, T., Herp, D., Zeyen, P., Salem-Altintas, R., Ridinger, J., Schmidtkunz, K., Robaa, D., Erdmann, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147535 · Cited by 48
Self-citationKrieger, V., Hamacher, A., Gertzen, C. G. W., Senger, J., Zwinderman, M. R. H., Marek, M., Romier, C., Dekker, F. J., Kurz, T., Jung, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00197 · Cited by 47
Self-citationSimoben, C., Robaa, D., Chakrabarti, A., Schmidtkunz, K., Marek, M., Lancelot, J., Kannan, S., Melesina, J., Shaik, T., Pierce, R., et al. (2018) · Molecules · doi:10.3390/molecules23030566 · Cited by 44
“Although we cannot directly correlate the inhibitory activity on smHDAC8 with the let al effect of J1036 on schistosomula, the high level of expression of this class I HDAC [21] in the par ite, and its validation a a stand-alone target by transcript knockdown [24], mean that its in ibition is sufficient to induce the…”
BackgroundMethodResultInfluentialSelf-citationPadalino, G., Ferla, S., Brancale, A., Chalmers, I. W., & Hoffmann, K. F. (2018) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2018.10.005 · Cited by 44
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
“31 4BZ9 14 August 2013 1784 Schistosoma mansoni [36] 32 3RQD 24 August 2011 788 Homo sapiens [37] 33 3SFF 20 July 2011 378 Homo sapiens [38] 34 3SFH 20 July 2011 378 Homo sapiens [38]”
Target-Based Molecular Modeling Strategies for Schistosomiasis Drug Discovery
Ferreira, L. L. G., Oliva, G., & Andricopulo, A. D. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.21 · Cited by 43
El‐Moslemany, R. M., Eissa, M. M., Ramadan, A. A., El-Khordagui, L. K., & El‐Azzouni, M. Z. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.03.038 · Cited by 39
Castañeda, C. A., Wolfson, N. A., Leng, K. R., Kuo, Y.-M., Andrews, A. J., & Fierke, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811026 · Cited by 38
One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity
Zessin, M., Kutil, Z., Meleshin, M., Nováková, Z., Ghazy, E., Kalbas, D., Marek, M., Romier, C., Sippl, W., Bařinka, C., et al. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00786 · Cited by 37
Self-citationGhazy, E., Zeyen, P., Herp, D., Hügle, M., Schmidtkunz, K., Erdmann, F., Robaa, D., Schmidt, M., Morales, E., Romier, C., et al. (2020) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2020.112338 · Cited by 27
Self-citationMoreno–Yruela, C., Bæk, M., Vrsanova, A.-E., Schulte, C., Maric, H. M., & Olsen, C. A. (2021) · Nature Communications · doi:10.1038/s41467-020-20250-9 · Cited by 36
Collins, J. N. R., & Collins, J. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005963 · Cited by 36
Identification of HDAC10 Inhibitors that Modulate Autophagy in Transformed Cells
Zeyen, P., Zeyn, Y., Herp, D., Mahmoudi, F., Yesiloglu, T. Z., Erdmann, F., Schmidt, M., Robaa, D., Romier, C., Ridinger, J., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114272 · Cited by 36
“Recombinant hHDAC8 was produced by Romier et al. in Strasbourg.36 The HDAC8 activity assays were performed according to the commercial HDAC8 Fluorometric Drug Discovery Kit [Fluor de Lys(R)-HDAC8, BML-KI178] corresponding to the manufacturer's instructions.”
Self-citationOliveira, G. (2014) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0013-2014 · Cited by 33
Self-citationReddy, D. N., Ballante, F., Chuang, T., Pirolli, A., Marrocco, B., & Marshall, G. R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01632 · Cited by 34
Anderson, L., Gomes, M. R., daSilva, L. F., Pereira, A. D. S. A., Mourão, M. D. M., Romier, C., Pierce, R. J., & Verjovski‐Almeida, S. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005539 · Cited by 31
Self-citationLiu, J., Zhu, Y., He, Y., Zhu, H., Gao, Y. Q., Li, Z., Zhu, J., Sun, X., Fang, F., Wen, H., et al. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1590241 · Cited by 30
“…4BZ6, 4BZ8, 4BZ9, 4LXZ, 4LY1, 5FCW, 5ICN, 5IWG, 5IX0 and 6G3O) (Bressi et al., 2010; Dowling, Gantt, Gattis, Fierke, & Christianson, 2008; Lauffer et al., 2013; Marek et al., 2013; Somoza et al., 2004; Tabackman, Frankson, Marsan, Perry, & Cole, 2016; Vannini et al., 2004; Wagner et al., 2016).”
Drugging the Schistosome Zinc-Dependent HDACs: Current Progress and Future Perspectives
Marek, M., Oliveira, G., Pierce, R. J., Jung, M., Sippl, W., & Romier, C. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.25 · Cited by 38
Self-citationPhotochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides
Wutz, D., Gluhacevic, D., Chakrabarti, A., Schmidtkunz, K., Robaa, D., Erdmann, F., Romier, C., Sippl, W., Jung, M., & König, B. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00976c · Cited by 31
Self-citationNew Molecular Targets and Strategies for Antimalarial Discovery
Aguiar, A. C. C., de Sousa, L. R. F., Garcia, C. R. S., Oliva, G., & Guido, R. V. C. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170830103003 · Cited by 29
Perfus‐Barbeoch, L., Castagnone‐Sereno, P., Reichelt, M., Fneich, S., Roquis, D., Pratx, L., Cosseau, C., Grunau, C., & Abad, P. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00211 · Cited by 34
“These advances in understanding S. mansoni epigenetic regulation have lead to the identification of promising new targets for the development of new drug to combat schistoso-miasis (Pierce et al., 2012; Lancelot et al., 2013; Marek et al., 2013).”
Saccoccia, F., Brindisi, M., Gimmelli, R., Relitti, N., Guidi, A., Saraswati, A. P., Cavella, C., Brogi, S., Chemi, G., Butini, S., et al. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00224 · Cited by 30
Self-citationStructure‐Based Design, Synthesis, and Biological Evaluation of Triazole‐Based smHDAC8 Inhibitors
Kalinin, D. V., Jana, S. K., Pfafenrot, M., Chakrabarti, A., Melesina, J., Shaik, T. B., Lancelot, J., Pierce, R. J., Sippl, W., Romier, C., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900583 · Cited by 30
Self-citationHDAC8 functions in spindle assembly during mouse oocyte meiosis
Zhang, K., Lu, Y., Jiang, C., Liu, W., Shu, J., Chen, X., Shi, Y., Wang, E., Wang, L., Hu, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15383 · Cited by 27
“In parasitic and viral infection, HDAC8 is required for centrosome cohesion and virus entry, and down-regulation of HDAC8 expression in schistosomula results in a decreased capability of their survival and maturation in infected mice [24, 25].”
BackgroundEvolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases
Scholte, L., Mourão, M. D. M., Pais, F. S.-M., Melesina, J., Robaa, D., Volpini, Â. C., Sippl, W., Pierce, R. J., Oliveira, G., & Nahum, L. A. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.05.011 · Cited by 31
Self-citationGeyer, K. K., Munshi, S. E., Whiteland, H., Fernández‐Fuentes, N., Phillips, D. W., & Hoffmann, K. F. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007107 · Cited by 27
Pereira, A. S. A., Silveira, G. O., Amaral, M. S., de Almeida, S. M. V., de Oliveira, J. F., de Lima, M. D. C. A., & Verjovski‐Almeida, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225425 · Cited by 25
Schiedel, M., Marek, M., Lancelot, J., Karaman, B., Almlöf, I., Schultz, J., Sippl, W., Pierce, R. J., Romier, C., & Jung, M. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114555307 · Cited by 27
“These species-selective changes were exploited to develop the smHDAC8 inhibitor J1075, which is capable of inducing apoptosis and mortality in schistosomes.(18) Another example for a smHDAC8 selective inhibitor is the thiol-based inhibitor discovered by Stolfa et al.”
BackgroundSelf-citationChemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
Dziwornu, G. A., Attram, H. D., Gachuhi, S., & Chibale, K. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00062k · Cited by 25
Long non-coding RNA levels can be modulated by 5-azacytidine in Schistosoma mansoni
Amaral, M. S., Maciel, L. F., Silveira, G. O., Olberg, G. G. D. O., Leite, J. V. P., Imamura, L. K., Pereira, A. S. A., Miyasato, P. A., Nakano, E., & Verjovski‐Almeida, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-78669-5 · Cited by 25
Bayer, T., Chakrabarti, A., Lancelot, J., Shaik, T. B., Hausmann, K., Melesina, J., Schmidtkunz, K., Marek, M., Erdmann, F., Schmidt, M., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800238 · Cited by 23
Self-citationHDAC8 as a target in drug discovery: Function, structure and design
Zhao, Q., Liu, H., Peng, J., Niu, H., Liu, J., Xue, H., Liu, W., Liu, X., Hao, H., Zhang, X., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116972 · Cited by 25
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-4000-z · Cited by 23
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., Wang, D., Hayatshahi, H. S., Shen, Y., Liu, J., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201908713 · Cited by 24
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Steimbach, R. R., Herbst‐Gervasoni, C. J., Merz, A., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200180 · Cited by 22
Self-citationModern approaches to accelerate discovery of new antischistosomal drugs
Neves, B. J., Muratov, E. N., Machado, R. B., Andrade, C. H., & Cravo, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1178230 · Cited by 25
“[46] Recent studies [71,72] showed that exposure to generic his-”
BackgroundGuidi, A., Saccoccia, F., Gennari, N., Gimmelli, R., Nizi, E., Lalli, C., Paonessa, G., Papoff, G., Bresciani, A., & Ruberti, G. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-3268-8 · Cited by 22
Vaca, H. R., Celentano, A. M., Macchiaroli, N., Kamenetzky, L., Camicia, F., & Rosenzvit, M. C. (2019) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2019.02.003 · Cited by 25
“We focused on the analysis of EcaHDAC8 and McoHDAC8, in order to determine if these proteins share structural di ff erences with HsaHDAC8 and structural similarities with SmpHDAC8, a validated drug target in S. mansoni .”
InfluentialSchistosome Sirtuins as Drug Targets
Lancelot, J., Cabezas‐Cruz, A., Caby, S., Marek, M., Schultz, J., Romier, C., Sippl, W., Jung, M., & Pierce, R. J. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.24 · Cited by 24
Self-citationBanerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1617782 · Cited by 21
“Apart from cancer, the involvement of HDAC8 in Uukuniemi virus and Influenza-A infections and in schistosomiasis has also been observed (Chakrabarti et al., 2015; 2016; Marek et al., 2013; Yamauchi et al., 2011).”
BackgroundHistone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
Ghazy, E., Abdelsalam, M. A. M., Robaa, D., Pierce, R. J., & Sippl, W. (2022) · Pharmaceuticals · doi:10.3390/ph15010080 · Cited by 21
“These two hits were then successfully cocrystallized with smHDAC8 and the crystal structure of the complex was solved [52,57].”
BackgroundSelf-citationCarneiro, V. C., da Silva, I. C. D. A., Amaral, M. S., Pereira, A. S. A., Silveira, G. O., Pires, D. D. S., Verjovski‐Almeida, S., Dekker, F. J., Rotili, D., Mai, A., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008332 · Cited by 19
“mansoni biology and the effect of inhibitors of histone deacetylases (HDACs 101 and SIRTs) or histone acetyltransferases (HATs) on parasite development and survival have 102 demonstrated the importance of these enzymes as potential therapeutic targets [8–12].”
BackgroundSelf-citationGene Expression Differences in Host Response toSchistosoma haematobiumInfection
Dupnik, K. M., Reust, M. J., Vick, K. M., Yao, B., Miyaye, D., Lyimo, E., Mukerebe, C., Mngara, J., Kalluvya, S. E., de Dood, C. J., et al. (2018) · Infection and Immunity · doi:10.1128/iai.00291-18 · Cited by 20
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Vaca, H. R., Celentano, A. M., Toscanini, M. A., Heimburg, T., Ghazy, E., Zeyen, P., Hauser, A., Oliveira, G., Elissondo, M. C., Jung, M., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009226 · Cited by 21
“mansoni [26] and have been applied to the structure-based design of selective inhibitors.”
MethodSelf-citationSimoben, C. V., Ghazy, E., Zeyen, P., Darwish, S., Schmidt, M., Romier, C., Robaa, D., & Sippl, W. (2021) · Molecules · doi:10.3390/molecules26092584 · Cited by 17
“Several studies have explored the major pharmacophoric features and interactions observed with HDAC inhibitors for the development of new drug candidates against schistosomiasis to target the parasite’s epigenome [49].”
BackgroundMethodSelf-citationIsophthalic Acid‐Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni
Stenzel, K., Chakrabarti, A., Melesina, J., Hansen, F. K., Lancelot, J., Herkenhöhner, S., Lungerich, B., Marek, M., Romier, C., Pierce, R. J., et al. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201700096 · Cited by 19
Self-citationMarek, M., Ramos‐Morales, E., Picchi, G. F. A., Bayer, T., Norström, C., Herp, D., Sales-Junior, P. A., Guerra-Slompo, E. P., Hausmann, K., Chakrabarti, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110129 · Cited by 18
Self-citationKinetics and thermodynamics of metal‐binding to histone deacetylase 8
Kim, B.-C., Pithadia, A. S., & Fierke, C. A. (2014) · Protein Science · doi:10.1002/pro.2623 · Cited by 21
López‐López, E., Barrientos‐Salcedo, C., Prieto-Martínez, F. D., & Medina‐Franco, J. L. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2020.04.001 · Cited by 16
Alzain, A. A., Mukhtar, R. M., Abdelmoniem, N., Elbadwi, F. A., Hussien, A., Garelnabi, E. A. E., Osman, W., Sherif, A. E., Khedr, A. I. M., Ghazawi, K. F., et al. (2023) · Metabolites · doi:10.3390/metabo13050658 · Cited by 16
“The urgent need for new drugs to treat eukaryotic parasitic infections, particularly neglected ones that lack effective vaccines and treatment options, is well recognized [30].”
BackgroundInhibition mechanism of SAHA in HDAC: a revisit
Zhou, J., Wu, R., & Luo, H. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp05633k · Cited by 18
Mohamed, A. H., El‐Nabi, S. H., Bayomi, A. E., & ABDEL-AAL, A. A. (2014) · Journal of Parasitic Diseases · doi:10.1007/s12639-014-0516-5 · Cited by 17
Elbadawi, M., Awadalla, M. K. A., Hamid, M. M. A., Mohamed, M. A., & Awad, T. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023915 · Cited by 17
“The MD-refined model comprises a single domain following the α-/β-fold class consisting of an eight-strand β-sheet surrounded by 14 α-helices, which is similar to HDACs homologues from other species, like Schistosoma [32].”
A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013–present)
Banerjee, S., Ghosh, B., Jha, T., & Adhikari, N. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2391289 · Cited by 15
Structure–Activity Relationship of Propargylamine‐Based HDAC Inhibitors
Wünsch, M., Senger, J., Schultheisz, P., Schwarzbich, S., Schmidtkunz, K., Michalek, C., Klaß, M., Goskowitz, S., Borchert, P., Praetorius, L., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700550 · Cited by 15
Self-citationCarbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition
King, K., Hauser, A., Melesina, J., Sippl, W., & Jung, M. (2018) · Molecules · doi:10.3390/molecules23020321 · Cited by 15
“Recombinant human HDAC1 and 6 were purchased from BPS Biosciences (San Diego, CA, USA), and recombinant human HDAC8 was produced as described before [24].”
MethodSelf-citationEpigenetics in Schistosomes: What We Know and What We Need Know
Liu, W. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00149 · Cited by 12
“The class I HDAC s, SmHDAC1, 3, and 8, were identified in S. mansoni (Oger et al., 2008; Marek et al., 2013; Singh and Pandey, 2015).”
BackgroundGhazy, E., Heimburg, T., Lancelot, J., Zeyen, P., Schmidtkunz, K., Truhn, A., Darwish, S., Simoben, C., Shaik, T., Erdmann, F., et al. (2021) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2021.113745 · Cited by 12
Self-citationRamamoorthi, R., Graef, K. M., & Dent, J. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.26 · Cited by 14
Colcerasa, A., Friedrich, F., Melesina, J., Moser, P., Vogelmann, A., Tzortzoglou, P., Neuwirt, E., Sum, M., Robaa, D., Zhang, L., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00229 · Cited by 14
Self-citationBallante, F., Reddy, D. R., Zhou, N., & Marshall, G. R. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.020 · Cited by 13
Metadata
- Authors
- Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., Renaud, J.-P., Oliveira, G., Sippl, W., Jung, M., Cavarelli, J., Pierce, R. J., & Romier, C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Martin Luther University Halle-Wittenberg (DE)
- University of Freiburg (DE)
- Fiocruz Minas (BR)
- Corresponding author
- Pierce, Raymond J.
- Romier, Christophe
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-26
- Volume
- 9
- Issue
- 9
- Pages
- e1003645
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3784479
- OpenAlex
- W1964248507
- Cited by
- 173
- References
- 68
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 13 · 2023: 7 · 2022: 15 · 2021: 11 · 2020: 20 · 2019: 18 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 16 · 2014: 13
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- European Commission (241865)
- Agence Nationale de la Recherche (ANR-10-INBS-0005)
- European Synchrotron Radiation Facility
- Institut National de la Santé et de la Recherche Médicale
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2009-3, 573839/2008-5)
- Centre National de la Recherche Scientifique
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (PPM-00439-10)
- French Infrastructure for Integrated Structural Biology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- Schistosoma mansoni, HDAC8, HDAC8 inhibitors, epigenetic drug targets, schistosomiasis, praziquantel resistance, crystal structure, structure-based inhibitor design, small molecule inhibitors, parasite infectivity, apoptosis, neglected tropical diseases
- MeSH terms
- Animals, Histone Deacetylases, Humans, Schistosoma mansoni, Helminth Proteins, Protein Structure, Secondary, Protein Folding, Epigenesis, Genetic, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.